Jeffrey A. Toretsky - Publications

Affiliations: 
Tumor Biology Georgetown University, Washington, DC 
Area:
Oncology, Biochemistry

82 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Selvanathan SP, Graham GT, Grego AR, Baker TM, Hogg JR, Simpson M, Batish M, Crompton B, Stegmaier K, Tomazou EM, Kovar H, Üren A, Toretsky JA. EWS-FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex. Nucleic Acids Research. PMID 31392992 DOI: 10.1093/nar/gkz699  0.32
2018 Çelik H, Sciandra M, Flashner B, Gelmez E, Kayraklıoğlu N, Allegakoen DV, Petro JR, Conn EJ, Hour S, Han J, Oktay L, Tiwari PB, Hayran M, Harris BT, Manara MC, ... Toretsky JA, et al. Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99. Oncogene. PMID 29382926 DOI: 10.1038/s41388-017-0080-4  0.32
2017 Zöllner SK, Selvanathan SP, Graham GT, Commins RMT, Hong SH, Moseley E, Parks S, Haladyna JN, Erkizan HV, Dirksen U, Hogarty MD, Üren A, Toretsky JA. Inhibition of the oncogenic fusion protein EWS-FLI1 causes G2-M cell cycle arrest and enhanced vincristine sensitivity in Ewing's sarcoma. Science Signaling. 10. PMID 28974650 DOI: 10.1126/scisignal.aam8429  0.32
2016 Minas TZ, Surdez D, Javaheri T, Tanaka M, Howarth M, Kang HJ, Han J, Han ZY, Sax B, Kream BE, Hong SH, Çelik H, Tirode F, Tuckermann J, Toretsky JA, et al. Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model. Oncotarget. PMID 27191748 DOI: 10.18632/oncotarget.9388  0.32
2016 Celik H, Bulut G, Han J, Graham GT, Minas TZ, Conn EJ, Hong SH, Pauly GT, Hayran M, Li X, Özdemirli M, Ayhan A, Rudek MA, Toretsky JA, Üren A. Ezrin Inhibition Upregulates Stress Response Gene Expression. The Journal of Biological Chemistry. PMID 27137931 DOI: 10.1074/jbc.M116.718189  0.32
2016 Saygideğer-Kont Y, Minas TZ, Jones H, Hour S, Çelik H, Temel I, Han J, Atabey N, Erkizan HV, Toretsky JA, Üren A. Ezrin Enhances EGFR Signaling and Modulates Erlotinib Sensitivity in Non-Small Cell Lung Cancer Cells. Neoplasia (New York, N.Y.). 18: 111-20. PMID 26936397 DOI: 10.1016/j.neo.2016.01.002  0.32
2015 Stieglitz E, Taylor-Weiner AN, Chang TY, Gelston LC, Wang YD, Mazor T, Esquivel E, Yu A, Seepo S, Olsen SR, Rosenberg M, Archambeault SL, Abusin G, Beckman K, Brown PA, ... ... Toretsky JA, et al. The genomic landscape of juvenile myelomonocytic leukemia. Nature Genetics. PMID 26457647 DOI: 10.1038/ng.3400  0.32
2015 Celik H, Hong SH, Colón-López DD, Han J, Saygideger Kont Y, Minas TZ, Swift M, Paige M, Glasgow E, Toretsky JA, Bosch J, Uren A. Identification of novel ezrin inhibitors targeting metastatic osteosarcoma by screening open access malaria box. Molecular Cancer Therapeutics. PMID 26358752 DOI: 10.1158/1535-7163.MCT-15-0511  0.32
2015 Zöllner SK, Rössig C, Toretsky JA. Synovial sarcoma is a gateway to the role of chromatin remodeling in cancer. Cancer Metastasis Reviews. 34: 417-28. PMID 26277104 DOI: 10.1007/s10555-015-9575-z  0.32
2015 Çelik H, Sajwan KP, Selvanathan SP, Marsh BJ, Pai AV, Kont YS, Han J, Minas TZ, Rahim S, Erkizan HV, Toretsky JA, Üren A. Ezrin Binds to DEAD-Box RNA Helicase DDX3 and Regulates Its Function and Protein Level. Molecular and Cellular Biology. 35: 3145-62. PMID 26149384 DOI: 10.1128/MCB.00332-15  0.32
2015 Selvanathan SP, Graham GT, Erkizan HV, Dirksen U, Natarajan TG, Dakic A, Yu S, Liu X, Paulsen MT, Ljungman ME, Wu CH, Lawlor ER, Üren A, Toretsky JA. Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing. Proceedings of the National Academy of Sciences of the United States of America. 112: E1307-16. PMID 25737553 DOI: 10.1073/pnas.1500536112  0.32
2015 Hong SH, Tilan JU, Galli S, Izycka-Swieszewska E, Polk T, Horton M, Mahajan A, Christian D, Jenkins S, Acree R, Connors K, Ledo P, Lu C, Lee YC, Rodriguez O, ... Toretsky JA, et al. High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases. Oncotarget. 6: 7151-65. PMID 25714031  0.32
2015 Erkizan HV, Schneider JA, Sajwan K, Graham GT, Griffin B, Chasovskikh S, Youbi SE, Kallarakal A, Chruszcz M, Padmanabhan R, Casey JL, Üren A, Toretsky JA. RNA helicase A activity is inhibited by oncogenic transcription factor EWS-FLI1. Nucleic Acids Research. 43: 1069-80. PMID 25564528 DOI: 10.1093/nar/gku1328  0.32
2015 Tilan JU, Krailo M, Barkauskas DA, Galli S, Mtaweh H, Long J, Wang H, Hawkins K, Lu C, Jeha D, Izycka-Swieszewska E, Lawlor ER, Toretsky JA, Kitlinska JB. Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival. Cancer. 121: 697-707. PMID 25387699 DOI: 10.1002/cncr.29090  0.32
2015 Hong SH, Tilan JU, Galli S, Izycka-Swieszewska E, Polk T, Horton M, Mahajan A, Christian D, Jenkins S, Acree R, Connors K, Ledo P, Lu C, Lee YC, Rodriguez O, ... Toretsky JA, et al. High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases Oncotarget. 6: 7151-7165.  0.32
2014 Rahim S, Minas T, Hong SH, Justvig S, Çelik H, Kont YS, Han J, Kallarakal AT, Kong Y, Rudek MA, Brown ML, Kallakury B, Toretsky JA, Üren A. A small molecule inhibitor of ETV1, YK-4-279, prevents prostate cancer growth and metastasis in a mouse xenograft model. Plos One. 9: e114260. PMID 25479232 DOI: 10.1371/journal.pone.0114260  0.32
2014 Toretsky JA, Wright PE. Assemblages: functional units formed by cellular phase separation. The Journal of Cell Biology. 206: 579-88. PMID 25179628 DOI: 10.1083/jcb.201404124  0.32
2014 Hong SH, Youbi SE, Hong SP, Kallakury B, Monroe P, Erkizan HV, Barber-Rotenberg JS, Houghton P, Ãœren A, Toretsky JA. Pharmacokinetic modeling optimizes inhibition of the 'undruggable' EWS-FLI1 transcription factor in Ewing Sarcoma. Oncotarget. 5: 338-50. PMID 24481407  0.32
2014 Paige M, Kosturko G, Bulut G, Miessau M, Rahim S, Toretsky JA, Brown ML, Üren A. Design, synthesis and biological evaluation of ezrin inhibitors targeting metastatic osteosarcoma. Bioorganic & Medicinal Chemistry. 22: 478-87. PMID 24326277 DOI: 10.1016/j.bmc.2013.11.003  0.32
2014 Borinstein SC, Barkauskas DA, Bernstein M, Goorin A, Gorlick R, Krailo M, Schwartz CL, Wexler LH, Toretsky JA. Analysis of serum insulin growth factor-1 concentrations in localized osteosarcoma: a children's oncology group study. Pediatric Blood & Cancer. 61: 749-52. PMID 24178953 DOI: 10.1002/pbc.24778  0.32
2014 Carmody Soni EE, Schlottman S, Erkizan HV, Uren A, Toretsky JA. Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma. Clinical Orthopaedics and Related Research. 472: 874-82. PMID 23716114 DOI: 10.1007/s11999-013-3065-9  0.32
2013 Tilan JU, Lu C, Galli S, Izycka-Swieszewska E, Earnest JP, Shabbir A, Everhart LM, Wang S, Martin S, Horton M, Mahajan A, Christian D, O'Neill A, Wang H, Zhuang T, ... ... Toretsky JA, et al. Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects. Oncotarget. 4: 2487-501. PMID 24318733  0.32
2013 Lee HJ, Yoon C, Schmidt B, Park do J, Zhang AY, Erkizan HV, Toretsky JA, Kirsch DG, Yoon SS. Combining PARP-1 inhibition and radiation in Ewing sarcoma results in lethal DNA damage. Molecular Cancer Therapeutics. 12: 2591-600. PMID 23966622 DOI: 10.1158/1535-7163.MCT-13-0338  0.32
2013 Abaan OD, Hendriks W, Uren A, Toretsky JA, Erkizan HV. Valosin containing protein (VCP/p97) is a novel substrate for the protein tyrosine phosphatase PTPL1. Experimental Cell Research. 319: 1-11. PMID 23018179 DOI: 10.1016/j.yexcr.2012.09.003  0.32
2012 Kirilyuk A, Shimoji M, Catania J, Sahu G, Pattabiraman N, Giordano A, Albanese C, Mocchetti I, Toretsky JA, Uversky VN, Avantaggiati ML. An intrinsically disordered region of the acetyltransferase p300 with similarity to prion-like domains plays a role in aggregation. Plos One. 7: e48243. PMID 23133622 DOI: 10.1371/journal.pone.0048243  0.32
2012 Schlottmann S, Erkizan HV, Barber-Rotenberg JS, Knights C, Cheema A, Uren A, Avantaggiati ML, Toretsky JA. Acetylation Increases EWS-FLI1 DNA Binding and Transcriptional Activity. Frontiers in Oncology. 2: 107. PMID 22973553 DOI: 10.3389/fonc.2012.00107  0.32
2012 Barber-Rotenberg JS, Selvanathan SP, Kong Y, Erkizan HV, Snyder TM, Hong SP, Kobs CL, South NL, Summer S, Monroe PJ, Chruszcz M, Dobrev V, Tosso PN, Scher LJ, Minor W, ... ... Toretsky JA, et al. Single enantiomer of YK-4-279 demonstrates specificity in targeting the oncogene EWS-FLI1. Oncotarget. 3: 172-82. PMID 22383402  0.32
2012 Smith MA, Kang MH, Reynolds CP, Kurmasheva RT, Alexander D, Billups CA, Toretsky JA, Houghton PJ. Evaluation of arsenic trioxide by the pediatric preclinical testing program with a focus on Ewing sarcoma. Pediatric Blood & Cancer. 59: 753-5. PMID 22315235 DOI: 10.1002/pbc.23391  0.32
2012 Bulut G, Hong SH, Chen K, Beauchamp EM, Rahim S, Kosturko GW, Glasgow E, Dakshanamurthy S, Lee HS, Daar I, Toretsky JA, Khanna C, Uren A. Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells. Oncogene. 31: 269-81. PMID 21706056 DOI: 10.1038/onc.2011.245  0.32
2011 Bulut G, Fallen S, Beauchamp EM, Drebing LE, Sun J, Berry DL, Kallakury B, Crum CP, Toretsky JA, Schlegel R, Üren A. Beta-catenin accelerates human papilloma virus type-16 mediated cervical carcinogenesis in transgenic mice. Plos One. 6: e27243. PMID 22087269 DOI: 10.1371/journal.pone.0027243  0.32
2011 Erkizan HV, Scher LJ, Gamble SE, Barber-Rotenberg JS, Sajwan KP, Üren A, Toretsky JA. Novel peptide binds EWS-FLI1 and reduces the oncogenic potential in Ewing tumors. Cell Cycle (Georgetown, Tex.). 10: 3397-408. PMID 21926473 DOI: 10.4161/cc.10.19.17734  0.32
2011 Ringer L, Sirajuddin P, Heckler M, Ghosh A, Suprynowicz F, Yenugonda VM, Brown ML, Toretsky JA, Uren A, Lee Y, MacDonald TJ, Rodriguez O, Glazer RI, Schlegel R, Albanese C. VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells. Cancer Biology & Therapy. 12: 818-26. PMID 21885916 DOI: 10.4161/cbt.12.9.17682  0.32
2011 Solomon DA, Kim T, Diaz-Martinez LA, Fair J, Elkahloun AG, Harris BT, Toretsky JA, Rosenberg SA, Shukla N, Ladanyi M, Samuels Y, James CD, Yu H, Kim JS, Waldman T. Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science (New York, N.Y.). 333: 1039-43. PMID 21852505 DOI: 10.1126/science.1203619  0.32
2011 Lu C, Tilan JU, Everhart L, Czarnecka M, Soldin SJ, Mendu DR, Jeha D, Hanafy J, Lee CK, Sun J, Izycka-Swieszewska E, Toretsky JA, Kitlinska J. Dipeptidyl peptidases as survival factors in Ewing sarcoma family of tumors: implications for tumor biology and therapy. The Journal of Biological Chemistry. 286: 27494-505. PMID 21680731 DOI: 10.1074/jbc.M111.224089  0.32
2011 Rahim S, Beauchamp EM, Kong Y, Brown ML, Toretsky JA, Üren A. YK-4-279 inhibits ERG and ETV1 mediated prostate cancer cell invasion. Plos One. 6: e19343. PMID 21559405 DOI: 10.1371/journal.pone.0019343  0.32
2011 Borinstein SC, Barkauskas DA, Krailo M, Scher D, Scher L, Schlottmann S, Kallakury B, Dickman PS, Pawel BR, West DC, Womer RB, Toretsky JA. Investigation of the insulin-like growth factor-1 signaling pathway in localized Ewing sarcoma: A report from the Children's Oncology Group Cancer. 117: 4966-4976. PMID 21480204 DOI: 10.1002/cncr.26112  0.32
2011 Wellstein A, Toretsky JA. Hunting ALK to feed targeted cancer therapy. Nature Medicine. 17: 290-1. PMID 21383740 DOI: 10.1038/nm0311-290  0.32
2011 Beauchamp EM, Ringer L, Bulut G, Sajwan KP, Hall MD, Lee YC, Peaceman D, Ozdemirli M, Rodriguez O, Macdonald TJ, Albanese C, Toretsky JA, Uren A. Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway. The Journal of Clinical Investigation. 121: 148-60. PMID 21183792 DOI: 10.1172/JCI42874  0.32
2010 Awad O, Yustein JT, Shah P, Gul N, Katuri V, O'Neill A, Kong Y, Brown ML, Toretsky JA, Loeb DM. High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition. Plos One. 5: e13943. PMID 21085683 DOI: 10.1371/journal.pone.0013943  0.32
2010 Lu C, Everhart L, Tilan J, Kuo L, Sun CCJ, Munivenkatappa RB, Jönsson-Rylander AC, Sun J, Kuan-Celarier A, Li L, Abe K, Zukowska Z, Toretsky JA, Kitlinska J. Neuropeptide y and its Y2 receptor: Potential targets in neuroblastoma therapy Oncogene. 29: 5630-5642. PMID 20676138 DOI: 10.1038/onc.2010.301  0.32
2010 Erkizan HV, Uversky VN, Toretsky JA. Oncogenic partnerships: EWS-FLI1 protein interactions initiate key pathways of Ewing's sarcoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 4077-83. PMID 20547696 DOI: 10.1158/1078-0432.CCR-09-2261  0.32
2010 Toretsky JA, Gorlick R. IGF-1R targeted treatment of sarcoma. The Lancet. Oncology. 11: 105-6. PMID 20036195 DOI: 10.1016/S1470-2045(09)70391-2  0.32
2010 Raygada M, Arthur DC, Wayne AS, Rennert OM, Toretsky JA, Stratakis CA. Juvenile xanthogranuloma in a child with previously unsuspected neurofibromatosis type 1 and juvenile myelomonocytic leukemia Pediatric Blood and Cancer. 54: 173-175. PMID 19785027 DOI: 10.1002/pbc.22297  0.32
2010 Toretsky JA, Üren A. Ewing's sarcoma family of tumors: Molecular targets need arrows Molecularly Targeted Therapy For Childhood Cancer. 373-400. DOI: 10.1007/978-0-387-69062-9_18  0.32
2009 Stylianou DC, Auf der Maur A, Kodack DP, Henke RT, Hohn S, Toretsky JA, Riegel AT, Wellstein A. Effect of single-chain antibody targeting of the ligand-binding domain in the anaplastic lymphoma kinase receptor. Oncogene. 28: 3296-306. PMID 19633684 DOI: 10.1038/onc.2009.184  0.32
2009 Erkizan HV, Kong Y, Merchant M, Schlottmann S, Barber-Rotenberg JS, Yuan L, Abaan OD, Chou TH, Dakshanamurthy S, Brown ML, Uren A, Toretsky JA. A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma. Nature Medicine. 15: 750-6. PMID 19584866 DOI: 10.1038/nm.1983  0.32
2009 Kim SY, Toretsky JA, Scher D, Helman LJ. The role of IGF-1R in pediatric malignancies. The Oncologist. 14: 83-91. PMID 19126579 DOI: 10.1634/theoncologist.2008-0189  0.32
2008 Chen K, Fallen S, Abaan HO, Hayran M, Gonzalez C, Wodajo F, MacDonald T, Toretsky JA, Uren A. Wnt10b induces chemotaxis of osteosarcoma and correlates with reduced survival. Pediatric Blood & Cancer. 51: 349-55. PMID 18465804 DOI: 10.1002/pbc.21595  0.32
2008 Abaan OD, Toretsky JA. PTPL1: a large phosphatase with a split personality. Cancer Metastasis Reviews. 27: 205-14. PMID 18265946 DOI: 10.1007/s10555-008-9114-2  0.32
2008 Endo Y, Beauchamp E, Woods D, Taylor WG, Toretsky JA, Uren A, Rubin JS. Wnt-3a and Dickkopf-1 stimulate neurite outgrowth in Ewing tumor cells via a Frizzled3- and c-Jun N-terminal kinase-dependent mechanism. Molecular and Cellular Biology. 28: 2368-79. PMID 18212053 DOI: 10.1128/MCB.01780-07  0.32
2008 French CA, Ramirez CL, Kolmakova J, Hickman TT, Cameron MJ, Thyne ME, Kutok JL, Toretsky JA, Tadavarthy AK, Kees UR, Fletcher JA, Aster JC. BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene. 27: 2237-42. PMID 17934517 DOI: 10.1038/sj.onc.1210852  0.32
2006 Aryee DN, Kreppel M, Bachmaier R, Uren A, Muehlbacher K, Wagner S, Breiteneder H, Ban J, Toretsky JA, Kovar H. Single-chain antibodies to the EWS NH(2) terminus structurally discriminate between intact and chimeric EWS in Ewing's sarcoma and interfere with the transcriptional activity of EWS in vivo. Cancer Research. 66: 9862-9. PMID 17047047 DOI: 10.1158/0008-5472.CAN-05-4042  0.32
2006 Adhikari S, Toretsky JA, Yuan L, Roy R. Magnesium, essential for base excision repair enzymes, inhibits substrate binding of N-methylpurine-DNA glycosylase Journal of Biological Chemistry. 281: 29525-29532. PMID 16901897 DOI: 10.1074/jbc.M602673200  0.32
2006 Toretsky JA, Erkizan V, Levenson A, Abaan OD, Parvin JD, Cripe TP, Rice AM, Lee SB, Uren A. Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase A. Cancer Research. 66: 5574-81. PMID 16740692 DOI: 10.1158/0008-5472.CAN-05-3293  0.32
2006 Brooks BP, Meck JM, Haddad BR, Bendavid C, Blain D, Toretsky JA. Factor VII deficiency and developmental abnormalities in a patient with partial monosomy of 13q and trisomy of 16p: case report and review of the literature. Bmc Medical Genetics. 7: 2. PMID 16412230 DOI: 10.1186/1471-2350-7-2  0.32
2005 Uren A, Toretsky JA. Ewing's sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent. Future Oncology (London, England). 1: 521-8. PMID 16556028 DOI: 10.2217/14796694.1.4.521  0.32
2005 Uren A, Fallen S, Yuan H, Usubütün A, Küçükali T, Schlegel R, Toretsky JA. Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression. Cancer Research. 65: 6199-206. PMID 16024621 DOI: 10.1158/0008-5472.CAN-05-0455  0.32
2005 Abaan OD, Levenson A, Khan O, Furth PA, Uren A, Toretsky JA. PTPL1 is a direct transcriptional target of EWS-FLI1 and modulates Ewing's Sarcoma tumorigenesis. Oncogene. 24: 2715-22. PMID 15782144 DOI: 10.1038/sj.onc.1208247  0.32
2005 Kitlinska J, Abe K, Kuo L, Pons J, Yu M, Li L, Tilan J, Everhart L, Lee EW, Zukowska Z, Toretsky JA. Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors. Cancer Research. 65: 1719-28. PMID 15753367 DOI: 10.1158/0008-5472.CAN-04-2192  0.32
2005 Uren A, Toretsky JA. Pediatric malignancies provide unique cancer therapy targets. Current Opinion in Pediatrics. 17: 14-9. PMID 15659957 DOI: 10.1097/01.mop.0000147904.84978.ae  0.32
2004 Uren A, Tcherkasskaya O, Toretsky JA. Recombinant EWS-FLI1 oncoprotein activates transcription. Biochemistry. 43: 13579-89. PMID 15491164 DOI: 10.1021/bi048776q  0.32
2004 French CA, Kutok JL, Faquin WC, Toretsky JA, Antonescu CR, Griffin CA, Nose V, Vargas SO, Moschovi M, Tzortzatou-Stathopoulou F, Miyoshi I, Perez-Atayde AR, Aster JC, Fletcher JA. Midline carcinoma of children and young adults with NUT rearrangement. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 4135-9. PMID 15483023 DOI: 10.1200/JCO.2004.02.107  0.32
2004 Uren A, Wolf V, Sun YF, Azari A, Rubin JS, Toretsky JA. Wnt/Frizzled signaling in Ewing sarcoma. Pediatric Blood & Cancer. 43: 243-9. PMID 15266408 DOI: 10.1002/pbc.20124  0.32
2003 Gober MD, Smith CC, Ueda K, Toretsky JA, Aurelian L. Forced expression of the H11 heat shock protein can be regulated by DNA methylation and trigger apoptosis in human cells. The Journal of Biological Chemistry. 278: 37600-9. PMID 12832417 DOI: 10.1074/jbc.M303834200  0.32
2003 Toretsky JA, Jenson J, Sun CC, Eskenazi AE, Campbell A, Hunger SP, Caires A, Frantz C, Hill JL, Stamberg J. Translocation (11;15;19): a highly specific chromosome rearrangement associated with poorly differentiated thymic carcinoma in young patients. American Journal of Clinical Oncology. 26: 300-6. PMID 12796605 DOI: 10.1097/01.COC.0000020960.98562.84  0.32
2003 Toretsky JA, Everly EM, Padilla-Nash HM, Chen A, Abruzzo LV, Eskenazi AE, Frantz C, Ried T, Stamberg J. Novel translocation in acute megakaryoblastic leukemia (AML-M7) Journal of Pediatric Hematology/Oncology. 25: 396-402. PMID 12759627 DOI: 10.1097/00043426-200305000-00009  0.32
2003 Uren A, Merchant MS, Sun CJ, Vitolo MI, Sun Y, Tsokos M, Illei PB, Ladanyi M, Passaniti A, Mackall C, Toretsky JA. Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells. Oncogene. 22: 2334-42. PMID 12700668 DOI: 10.1038/sj.onc.1206330  0.32
2001 Toretsky JA, Zitomersky NL, Eskenazi AE, Voigt RW, Strauch ED, Sun CC, Huber R, Meltzer SJ, Schlessinger D. Glypican-3 expression in Wilms tumor and hepatoblastoma. Journal of Pediatric Hematology/Oncology. 23: 496-9. PMID 11878776 DOI: 10.1097/00043426-200111000-00006  0.32
2001 Simons-Evelyn M, Bailey-Dell K, Toretsky JA, Ross DD, Fenton R, Kalvakolanu D, Rapoport AP. PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cells. Blood Cells, Molecules & Diseases. 27: 825-9. PMID 11783945 DOI: 10.1006/bcmd.2001.0452  0.32
2001 Toretsky JA, Steinberg SM, Thakar M, Counts D, Pironis B, Parente C, Eskenazi A, Helman L, Wexler LH. Insulin-like growth factor type 1 (IGF-1) and igf binding protein-3 in patients with ewing sarcoma family of tumors Cancer. 92: 2941-2947. PMID 11753970 DOI: 10.1002/1097-0142(20011201)92:11<2941::AID-CNCR10072>3.0.CO;2-C  0.32
2001 Waldrop C, Kathuria SS, Toretsky JA, Sun CCJ. Myoepithelioma metastatic to the orbit American Journal of Ophthalmology. 132: 594-596. PMID 11589895 DOI: 10.1016/S0002-9394(01)01060-1  0.32
2001 Merino ME, Navid F, Christensen BL, Toretsky JA, Helman LJ, Cheung NKV, Mackall CL. Immunomagnetic purging of Ewing's sarcoma from blood and bone marrow: Quantitation by real-time polymerase chain reaction Journal of Clinical Oncology. 19: 3649-3659. PMID 11504746  0.32
2000 Young G, Toretsky JA, Campbell AB, Eskenazi AE. Recognition of common childhood malignancies American Family Physician. 61: 2144-2154. PMID 10779255  0.32
1999 Toretsky JA, Thakar M, Eskenazi AE, Frantz CN. Phosphoinositide 3-hydroxide kinase blockade enhances apoptosis in the Ewing's sarcoma family of tumors Cancer Research. 59: 5745-5750. PMID 10582694  0.32
1999 Souza RF, Wang S, Thakar M, Smolinski KN, Yin J, Zou TT, Kong D, Abraham JM, Toretsky JA, Meltzer SJ. Expression of the wild-type insulin-like growth factor II receptor gene suppresses growth and causes death in colorectal carcinoma cells. Oncogene. 18: 4063-8. PMID 10435587 DOI: 10.1038/sj.onc.1202768  0.32
1999 Choo-Kang LR, Jones DM, Fehr JJ, Eskenazi AE, Toretsky JA. Cerebral edema and priapism in an adolescent with acute lymphoblastic leukemia Pediatric Emergency Care. 15: 110-112. PMID 10220081  0.32
1997 Toretsky JA, Kalebic T, Blakesley V, LeRoith D, Helman LJ. The insulin-like growth factor-I receptor is required for EWS/FLI-1 transformation of fibroblasts Journal of Biological Chemistry. 272: 30822-30827. PMID 9388225 DOI: 10.1074/jbc.272.49.30822  0.32
1997 Toretsky JA, Helman LJ. Cytogenetics and experimental models Current Opinion in Oncology. 9: 342-347. PMID 9251884  0.32
1997 Schulte TW, Toretsky JA, Ress E, Helman L, Neckers LM. Expression of PAX3 in Ewing's sarcoma family of tumors Biochemical and Molecular Medicine. 60: 121-126. PMID 9169092 DOI: 10.1006/bmme.1997.2567  0.32
1997 Toretsky JA, Connell Y, Neckers L, Bhat NK. Inhibition of EWS-FLI-1 fusion protein with antisense oligodeoxynucleotides Journal of Neuro-Oncology. 31: 9-16. PMID 9049825  0.32
1996 Toretsky JA, Helman LJ. Involvement of IGF-II in human cancer Journal of Endocrinology. 149: 367-372. PMID 8691094 DOI: 10.1677/joe.0.1490367  0.32
1995 Toretsky JA, Neckers L, Wexler LH. Detection of (11; 22)(q24;q12) translocation-bearing cells in peripheral blood progenitor cells of patients with ewing's sarcoma family of tumors Journal of the National Cancer Institute. 87: 385-386. PMID 7853420 DOI: 10.1093/jnci/87.5.385  0.32
Show low-probability matches.